Literature DB >> 23108122

Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death.

Pablo G Sanchez1, Gregory J Bittle, Katrina Williams, Chetan Pasrija, Kai Xu, Xufeng Wei, Zhongjun J Wu, Bartley P Griffith.   

Abstract

OBJECTIVE: To evaluate the effects of prearrest heparin administration on lung quality in a model of donation after cardiac death (DCD), and to assess the potential application of ex vivo lung perfusion (EVLP) in the identification of better grafts from the DCD donor pool.
METHODS: Cardiac death was induced by electric shock in 10 pigs. One group received a prearrest heparin dose of 300 units/kg (H group, n = 5) and the other did not (NH group, n = 5). Animals remained at room temperature for 1 hour without ventilation, defining the warm ischemic time. After harvest, the lungs underwent 6 hours of cold ischemia before being evaluated with EVLP for 4 hours.
RESULTS: Static compliance 28 ± 3 versus 29 ± 2 (Cstat-cm H2O), pulmonary vascular resistance (PVR) 593 ± 127 versus 495 ± 70 (PVR-dyn·s/cm), and oxygenation 327 ± 32 versus 330 ± 28 (ΔPO2-mm Hg) remained stable from the beginning until the end of EVLP in the H group. In the NH group, Cstat started to decline after the first hour (25 ± 2 vs 21 ± 2), ΔPO2 after hour 2 (265 ± 44 vs 207 ± 44), and PVR started to increase after hour 3 (765 ± 132 vs 916 ± 168). Significant differences between the groups were observed at the end of EVLP (P < 0.001). Parameters of lung quality after EVLP also showed significant differences between the groups: wet weight-to-dry weight ratio (P < 0.001), protein in the bronchial lavage (P < 0.01), Na + K-ATPase activity (P < 0.001), and E-selectin (P < 0.001) in the perfusate.
CONCLUSIONS: Prearrest heparin administration improved organ function by preserving endothelial homeostasis. EVLP proved to be a useful platform for assessing DCD lungs, providing reliable means of discriminating injured grafts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23108122     DOI: 10.1097/SLA.0b013e318273bef1

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

Review 1.  Ex vivo lung perfusion.

Authors:  Tiago N Machuca; Marcelo Cypel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

Review 2.  Donors after cardiocirculatory death and lung transplantation.

Authors:  Ilhan Inci
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.

Authors:  Matthew L Stone; Ashish K Sharma; Valeria R Mas; Ricardo C Gehrau; Daniel P Mulloy; Yunge Zhao; Christine L Lau; Irving L Kron; Mary E Huerter; Victor E Laubach
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

4.  Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.

Authors:  Mohammed Fakhro; Ellen Broberg; Lars Algotsson; Lennart Hansson; Bansi Koul; Ronny Gustafsson; Per Wierup; Richard Ingemansson; Sandra Lindstedt
Journal:  J Cardiothorac Surg       Date:  2017-11-25       Impact factor: 1.637

5.  Endothelin-Converting Enzyme 1 and Vascular Endothelial Growth Factor as Potential Biomarkers during Ex Vivo Lung Perfusion with Prolonged Hypothermic Lung-Sparing.

Authors:  Claudia Hernández-Jiménez; J Raúl Olmos-Zúñiga; Matilde Baltazares-Lipp; Rogelio Jasso-Victoria; Adrián Polo-Jerez; María Teresa Pérez-López; Luis Florentino Vázquez-Justiniano; Néstor Emmanuel Díaz-Martínez; Miguel Gaxiola-Gaxiola; Laura Romero-Romero; Axel Edmundo Guzmán-Cedillo; Mario Enrique Baltazares-Lipp; Juan Carlos Vázquez-Minero; Luis Horacio Gutiérrez-González; Marcelino Alonso-Gómez; Mariana Silva-Martínez
Journal:  Dis Markers       Date:  2022-02-07       Impact factor: 3.434

6.  Premortem anticoagulation timing and dose in donation after circulatory death: multicentre study of associations with graft function.

Authors:  Andreas H Kramer; Kerry Holliday; Sean Keenan; George Isac; Demetrius J Kutsogiannis; Norman M Kneteman; Peter Kim; Adrian Robertson; Peter W Nickerson; Lee Anne Tibbles
Journal:  Can J Surg       Date:  2022-07-28       Impact factor: 2.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.